Search Results - "Hoshiya, Makiko"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Mechanisms of mitogen-activated protein kinase activation in experimental diabetes by AWAZU, M, ISHIKURA, K, HIDA, M, HOSHIYA, M

    “…Various growth factors and vasoactive substances are implicated in the pathogenesis of renal growth seen in early diabetes mellitus (DM). Mitogen-activated…”
    Get full text
    Journal Article
  2. 2

    Mullerian-Inhibiting Substance Regulates NF-κB Signaling in the Prostate in vitro and in vivo by Segev, Dorry L., Hoshiya, Yasunori, Hoshiya, Makiko, Tran, Trinh T., Carey, Jennifer L., Stephen, Antonia E., MacLaughlin, David T., Donahoe, Patricia K., Maheswaran, Shyamala

    “…Mullerian-inhibiting substance (MIS) is a member of the transforming growth factor β superfamily, a class of molecules that regulates growth, differentiation,…”
    Get full text
    Journal Article
  3. 3

    Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells by Hoshiya, Yasunori, Gupta, Vandana, Segev, Dorry L., Hoshiya, Makiko, Carey, Jennifer L., Sasur, Laura M., Tran, Trinh T., Ha, Thanh U., Maheswaran, Shyamala

    Published in Molecular and cellular endocrinology (15-12-2003)
    “…The MIS type II receptor is expressed at high levels in the Mullerian duct and in Sertoli cells and granulosa cells of the embryonic and adult gonads. The…”
    Get full text
    Journal Article
  4. 4

    Müllerian Inhibiting Substance Regulates NFκB Signaling and Growth of Mammary Epithelial Cells in Vivo by Segev, Dorry L., Hoshiya, Yasunori, Stephen, Antonia E., Hoshiya, Makiko, Tran, Trinh T., MacLaughlin, David T., Donahoe, Patricia K., Maheswaran, Shyamala

    Published in The Journal of biological chemistry (20-07-2001)
    “…Müllerian inhibiting substance (MIS) inhibits breast cancer cell growth in vitro through interference with cell cycle progression and induction of apoptosis, a…”
    Get full text
    Journal Article
  5. 5

    Eicosapentaenoic acid inhibits PDGF-induced mitogenesis and cyclin D1 expression via TGF-β in mesangial cells by Hida, Mariko, Fujita, Hisayo, Ishikura, Kenji, Omori, Sayu, Hoshiya, Makiko, Awazu, Midori

    Published in Journal of cellular physiology (01-08-2003)
    “…Eicosapentaenoic acid (EPA), an ω‐3 polyunsaturated fatty acid derived from fish oil, is efficacious in glomerular diseases where mesangial proliferation is a…”
    Get full text
    Journal Article
  6. 6

    Trapidil Inhibits Platelet-Derived Growth Factor-Stimulated Mitogen-Activated Protein Kinase Cascade by Hoshiya, Makiko, Awazu, Midori

    Published in Hypertension (Dallas, Tex. 1979) (01-02-1998)
    “…Trapidil, an antiplatelet drug, has been shown to reduce restenosis after angioplasty. It exerts its action, at least in part, by inhibiting vascular smooth…”
    Get full text
    Journal Article
  7. 7

    Mullerian-inhibiting substance regulates NF-kappaB signaling in the prostate in vitro and in vivo by Segev, Dorry L, Hoshiya, Yasunori, Makiko Hoshiya Trinh T Tran

    “…Mullerian-inhibiting substance (MIS) is a member of the transforming growth factor beta superfamily, a class of molecules that regulates growth,…”
    Get full text
    Journal Article
  8. 8

    Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene by Hoshiya, Makiko, Christian, Benjamin P., Cromie, William J., Kim, Hyung, Zhan, Yong, MacLaughlin, David T., Donahoe, Patricia K.

    “…BACKGROUND Persistent Mullerian duct syndrome (PMDS) is a rare form of male pseudohermaphroditism that is characterized by the persistence of Mullerian…”
    Get full text
    Journal Article
  9. 9

    Müllerian Inhibiting Substance Regulates NFκB Signaling and Growth of Mammary Epithelial Cells in Vivo by Dorry L. Segev, Yasunori Hoshiya, Antonia E. Stephen, Makiko Hoshiya, Trinh T. Tran, David T. MacLaughlin, Patricia K. Donahoe, Shyamala Maheswaran

    Published in The Journal of biological chemistry (20-07-2001)
    “…Müllerian inhibiting substance (MIS) inhibits breast cancer cell growth in vitro through interference with cell cycle progression and induction of apoptosis,…”
    Get full text
    Journal Article